Implementing the ECDC Action Plan for Measles and Rubella
In recent years, Europe has experienced a resurgence of measles and rubella, and several countries have experienced large outbreaks. The reasons behind this resurgence are complex, but the root cause of the continued measles and rubella transmission in the EU is the sub-optimal uptake of the measles-mumps-rubella (MMR) vaccine, leading to an accumulation of susceptible individuals. ECDC identified five key areas to support Member States in their efforts to achieve the WHO measles and rubella elimination goal: a thorough analysis of the problem, data for action, strengthening of public health capacities, evidence-based communication, and regional and international collaboration.
For each area, specific activities were identified and an ECDC ‘Action Plan for Measles and Rubella’ with more than 20 deliverables was launched in 2012.
This report describes all activities and accomplishments based on the ‘Action Plan for Measles and Rubella’ as of March 2014.
Retrospective surveillance and enhanced case-finding of congenital rubella syndrome cases
16 Nov 2018 - The generic protocol presented in this document was developed for ECDC by fellows of the EPIET programme to provide EU/EEA Member States with an adaptable tool to estimate the incidence of congenital rubella syndrome (CRS) cases in their countries.
Antenatal screening approaches effective in preventing MTCT of HIV, HBV, syphilis and rubella in vulnerable populations
21 Mar 2017 - In order to collect evidence on effective types of antenatal screening intervention that are effective for population groups vulnerable to MTCT, a review of the existing published literature was performed.
Effectiveness and cost-effectiveness of antenatal screening for HIV, hepatitis B, syphilis and rubella susceptibility
21 Mar 2017 - This literature review was conducted as part of a project evaluating the effectiveness of antenatal screening for HIV, hepatitis B, syphilis and rubella susceptibility in EU/EEA Member States.